Table 3.
Number of products substituted perioperatively for both cohorts. P – level of significance. ∗combined in the product Haemate ®.
| Product | Study cohort, n (%) | Control cohort, n (%) | P |
|---|---|---|---|
| FXIII | 22 (11.1) | – | – |
| Fibrinogen | 22 (11.1) | 7 (3.5) | .048 |
| vWF∗ | 17 (8.7) | – | – |
| Faktor VIII∗ | 17 (8.7) | – | – |
| Tranexamic acid | 43 (21.8) | 16 (8.1) | .020 |
| Platelet transfusion | 24 (12.2) | 4 (2) | .038 |
| Prothrombin complex | 5 (2.5) | 2 (1.0) | .449 |
| Calcium gluconate | 8 (4.1) | 22 (11.2) | .012 |
| Fresh frozen plasma | 1 (0.5) | 5 (2.5) | .215 |
| Desmopressin | 10 (5.1) | 10 (5.1) | 1.000 |